CAH · 10-Q · 2026Q3 · Full report

Segment Asset Growth

CARDINAL HEALTH INC · 2026-11-05 · Importance 30 · Surprise 14 · From source text

Total assets increased 3.9% to $59,544 million at September 30, 2026, from $57,299 million at June 30, 2026, a rise of $2,245 million. Pharmaceutical and Specialty Solutions assets increased $1,695 million to $42,472 million, while Global Medical Products and Distribution assets rose $168 million to $6,819 million. Other assets increased $171 million to $4,269 million, and Corporate assets rose $211 million to $5,984 million.

Key facts

• Cardinal Health’s consolidated balance-sheet total assets were $59.544 billion at September 30, 2026, compared with $57.299 billion at June 30, 2026. source
• Pharmaceutical and Specialty Solutions assets were $42,472 million at September 30, 2026, compared with $40,777 million at June 30, 2026. source
• Global Medical Products and Distribution assets were $6,819 million at September 30, 2026, compared with $6,651 million at June 30, 2026. source
• Corporate assets were $5,984 million at September 30, 2026, compared with $5,773 million at June 30, 2026. source
• Other assets were $4,269 million at September 30, 2026, compared with $4,098 million at June 30, 2026. source
• Total property and equipment, net was $2,999 million at September 30, 2026, compared with $3,031 million at June 30, 2026. source
• Property and equipment, net in the United States was $2,579 million at September 30, 2026, compared with $2,607 million at June 30, 2026. source
• Navista goodwill testing resulted in a $184 million pretax impairment charge during the three months ended March 31, 2026, primarily due to an increased discount rate following changes in business plan risk profile. source

Impact estimates